Herbalife enters the week ahead of its August 5 earnings with a stock that has recovered 10% over the past month — yet short sellers are rebuilding positions at the fastest weekly pace in months, even as insiders sold aggressively into that strength.
The tension inside the short book is the week's clearest signal. Short interest jumped 19% in a single week to 8.0% of free float — a sharp acceleration from the mid-June trough of roughly 6.6%. That move stands out against a backdrop where the stock itself gained nearly 10% on the week, meaning new shorts are pressing into a rising price. The lending market offers no friction for them: availability is deeply comfortable at 561% of short interest, well above the 52-week low of 391%, and cost to borrow remains negligible at under 0.5%. That combination — rising SI, loose borrow, low cost — suggests conviction rather than a technical forced cover. Options traders are not signalling the same alarm; the put/call ratio is running at 0.54, marginally below its 20-day average and a long way from either extreme of its 52-week range. The positioning picture therefore splits along instrument lines: short sellers are adding, while options traders remain relatively relaxed.
What the Street thinks is worth watching alongside that. Analyst data becomes stale past the 14-day threshold, and the most recent action on record is an RBC Capital target cut to $16 back in late April — already more than two months old. The mean price target across the three covering analysts is $18.33, implying around 40% above the current $13.11 close. EV/EBITDA is running near 4.5x and the P/E near 4.3x — undemanding multiples that underpin the bull case. EPS momentum factor scores reinforce the tone: the 90-day reading ranks in the 79th percentile and the forward-year growth rank in the 76th, suggesting estimates are moving in the right direction. The short score, at 57, is middling and has been broadly range-bound between 54 and 59 over the past two weeks — elevated enough to warrant attention but not flashing extreme bearishness.
Institutional ownership tells its own story. The Baupost Group and Route One — both known for patient, deep-value mandates — hold a combined 17% of shares. BlackRock added 686,000 shares through June 30, and Fidelity (FMR) built a meaningful position during the quarter, adding over 1.4 million shares. Those are not the footprints of forced sellers. But insiders moved in the opposite direction. COO Troy Hicks sold more than 110,000 shares across three transactions in May, collecting roughly $1.5 million. Chief Commercial Officer Frank Lamberti sold nearly 143,000 shares in the same month for over $1.9 million. The 90-day net insider position is technically positive at 311,952 shares — but that figure is dominated by a small director purchase of 1,200 shares at $11.31 in June, dwarfed in value by the executive selling. The narrative the insider data tells is one of management monetising the stock's recovery from its April lows.
Those April lows followed a severe earnings reaction. The May 6 print triggered an 11% single-day drop and a 20% five-day decline — the kind of move that explains both why the stock spent weeks in the low-$11s and why short sellers are now rebuilding. The next print is due August 5. Between now and then, the question is whether the short rebuild is a rational hedge against another disappointment or a position that will face pressure if the stock continues to grind higher into results — with Baupost, Fidelity, and BlackRock all holding their ground behind it.
See the live data behind this article on ORTEX.
Open HLF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
